Supporting Treatment Access and Recovery in COD
Supporting Treatment Access and Recovery in Co-Occurring Opioid Use and Mental Health Disorders
University of Massachusetts, Worcester
1,000 participants
Mar 11, 2022
INTERVENTIONAL
Conditions
Summary
This 4-year study will randomize 1,000 people with co-occurring opioid use and mental health disorders (COD) at medication for opioid use disorder (MOUD) clinics to evaluate the effectiveness of MISSION, a multi-component team approach, or its components with MOUD versus MOUD alone, as well as the incremental benefits of MISSION or its components for improving outcomes. We expect that individuals receiving MISSION or its parts + MOUD will show greater improvement over MOUD alone on: engagement, substance use, and mental health.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
medication management
offering intensive community-based services that decrease in intensity over time
including 11 recovery-oriented sessions from someone with lived experience of co-occurring disorders
comprised of 13 structured co-occurring disorders treatment sessions
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05138614